Clindamycin versus Phenoxymethylpenicillin in the Treatment of Acute Orofacial Infections

Save this PDF as:
Size: px
Start display at page:

Download "Clindamycin versus Phenoxymethylpenicillin in the Treatment of Acute Orofacial Infections"

Transcription

1 Article Vol. 11. No Eur. J. Clin, Microbiol. Infect. Dis., December 1992, p /92/ $3.00/0 Clindamycin versus Phenoxymethylpenicillin in the Treatment of Acute Orofacial Infections L. von Konow 1, Elk, K6ndell 1, C.E. Nord 2,3., A. Heimdahl 1 The efficacy of clindamycin and phenoxymethylpenicillin in the treatment of orofacial infections was compared in a randomised study in 60 patients: 30 patients received clindamycin 150 mg every 6 h for seven days, and 30 received phenoxymethylpenicillin 1 g every 12 h for seven days. Where indicated incision and drainage were carried out. All patients but one in each group responded satisfactorily to treatment. Although the clindamycin group had a shorter duration of pain, swelling and fever and more favourable laboratory findings, the differences between the groups were not statistically significant. Of the 60 microbiological specimens 23 yielded only anaerobic bacteria, 34 both anaerobic and aerobic bacteria, two aerobic bacteria only and one no growth. In the penicillin group one case of severe diarrhoea occurred, and six patients in the clindamycin group had moderate to severe gastrointestinal discomfort, including one case of Clostridium difficile associated diarrhoea. This difference was however not statistically significant. The results support the continued use of penicillin for treatment of orofacial infections, with clindamycin serving as an effective alternative. Anaerobic bacteria play a dominant role in a variety of human infections (1), and are the major pathogens in orofacial infections (2-5). Although penicillin has long been the drug of choice for the treatment of orofacial infections, clinical failures in cases involving penicillin-resistant beta-lactamase-producing Bacteroides species have been reported (6-9). Beta-lactamase producing Bacteroides species occur frequently in the oral cavity, especially subsequent to penicillin therapy (10). With increasing use of antimicrobial agents, orofacial infections caused by penicillinresistant Bacteroides strains may be expected to become more frequent. In vitro, virtually all strictly anaerobic strains, including penicillinresistant species isolated from orofacial infections, are highly sensitive to for instance clindamycin and nitroimidazoles (6, 3). These agents are potential alternatives to penicillin for treatment of orofacial infections caused by penicillinresistant anaerobic bacteria. Nitroimidazoles are less often associated with adverse gastrointestinal effects than clindamycin (11, 12). However, in patients with a risk of endocarditis or in patients i Department of Oral Surgery and ZDepartment of Microbiology, Huddinge University Hospital, Karolinska Institute, S Huddinge, Sweden. 3 National Bacteriological Laboratory, Stockholm, Sweden. suffering from immunodeficiency, the use of nitroimidazoles may be contra-indicated because of their limited activity against viridans streptococci (13, 14). The aim of the present study was to compare penicillin and clindamycin with respect to microbiological and clinical efficacy and adverse effects in the treatment of orofacial infections. Materials and Methods Patients. Sixty patients (36 males and 24 females, mean age 46 years, range years) presenting at the Department of Oral Surgery, Huddinge University Hospital, Karolinska Institute, with acute orofacial infections of dentoalveolar origin of less than one week's duration participated in the trial. The spectrum of infections included periapical (most common), periodontal and postoperative infections after dentoalveolar surgery, with or without spread into orofacial spaces. None of the patients had received any antimicrobial agents during the preceding two months. Antimicrobial Therapy. Patients were allocated at random, using Doeumenta Geigy's randomising tables, to receive treatment with phenoxymethylpenicillin tablets (Leo AB, Sweden) I g q 12 h for seven days or clindamycin tablets (Upjohn, USA) 150 mg q 6 h for seven days. All patients except one in the penicillin group and three in the clindamycin group were treated surgically

2 1130 Eur. J. Clin. Microbiol. Infect. Dis. with drainage. These four patients received antibiotic therapy only. All patients were examined on days 1, 3, 7 and 14 by the same surgeon. Patient compliance was monitored by tablet counts on days 3 and 7 and by collecting blood samples at all visits to assay serum concentrations of penicillin and clindamycin. The clinical course of the infection was fouowed by documenting the presence and severity of fever, swelling, pain and disturbance of sleep. The response to treatment was regarded as poor when clinical symptoms had not disappeared or markedly subsided within five days, or when symptoms recurred during the observation period (15). Patients were urged to report immediately any sign of gastrointestinal disorder or other discomfort. Clinical Laboratory Investigations. Blood samples were collected on days 1 and 14 for determining the haemoglobin level, erythrocyte sedimentation rate, total white blood cell count, and SGOT, SGPT and alkaline phosphatase levels. On days 1, 3, 7 and 14, blood was drawn from the finger tip to determine the serum concentration of penicillin and clindamycin respectively. Microbiological Investigations. On day 1 a specimen of pus was aspirated through intact mucosa or skin after disinfection. The syringes were sealed with a sterile butyl rubber stopper and transported immediately to the microbiological laboratory. The samples were immediately inoculated onto solid and into liquid media and incubated aerobically and anaerobically for up to ten days. The anaerobic media were manipulated in an anaerobic chamber (Coy, USA). Aerobic and anaerobic bacteria were identified morphologically, biochemically and by gas liquid chromatographic analysis of metabolic end-products, as described by Lennette et al. (16). Faecal specimens from patients with diarrhoea were assayed for Clostridium difficile and its toxins as described by Aronsson et al. (11). Susceptibility Testing. The minimum inhibitory concentrations (MIC) of phenoxymethylpenicillin and dindamycin for the different bacterial strains were determined by the agar dilution method (17, 18), using PDM- Antibiotic Sensitivity Medium (BioDisk, Sweden). Agar plates containing doubling concentrations from to 64 mg/i of phenoxymethylpenicillin and clindamycin were inoculated with the different bacterial isolates. Aerobically incubated plates were read after incubation for 24 h. Anaerobic plates were incubated at 37 C in anaerobic jars (GasPak; BBL, USA) and read after 48 h. Penicillin resistance was considered to be present at an MIC > 1 mg/l and clindamycin resistance at an MIC > 4 mg/l (18). Statistical Analysis. Differences in efficacy between the two treatment groups were analysed by Mann-Whitney's U-test and differences in adverse effects by Fisher's twotailed exact test. Results Patient Compliance. All patients took the tablets in accordance with instructions as revealed by the antibiotic concentrations assayed at all visits. Clinical Outcome. Three patients in the penicillin group discontinued treatment, one because of diarrhoea, one because of the distance to the clinic and one for unknown reasons. Two patients in the clindamycin group discontinued treatment before day 3 because of diarrhoea. The treatment response was satisfactory in all other patients except for one in each group. The patient in the penicillin group had an abscess originating from an infected residual cyst in the upper dental alveolar process, and the patient in the clindamycin group had a periapical abscess originating from an upper canine. On day 7 both patients still demonstrated swelling, fever and presence of purulent material in spite of repeated incisions. Subsequent to incision on day 7 both infections subsided within a few days. Compared to the penicillin group the duration of pain, swelling and fever was less in the clindamycin group and the laboratory findings also tended to be more favourable, but the differences were not statistically significant (Mann-Whitney's U-test). The data are shown in Table 1. Clinical Laboratory Tests. With respect to the erythrocyte sedimentation rate and total white blood cell count there were no differences between the two groups during treatment. None of Table 1: Duration of pain, swelling, sleep disturbance and fever (temperature 37.5 *C or above) in the two patient groups. Duration (days) in penicillin group Duration (days) in clindamycin group Symptom Total Median Range Total Median Range Pain Swelling Sleep disturbance Fever

3 Vo1.11, Table 2: Number of aerobic and anaerobic organisms isolated from 59 specimens from patients in the penicillin and elindamycin groups. Organisms Penicillin Clindamycin group group Gram-positive cocci Staphylococcus epidermidis 1 3 Staphylococcus sap roph yticus 3 1 Streptococcus milleri 14 4 Streptococcus mitior 9 9 Streptococcus spp. 3 4 Micrococcus spp. 1 0 Gram-negative cocci 0 1 Gram-positive rods 0 1 Gram-negative rods Haernophilus influenzae 3 0 Haernophilus parainfluenzae 0 2 Other 1 4 Total number of aerobic isolates Gram-positive cocci Streptococcus constellatus 6 0 Streptococcus intermedius 8 8 Streptococcus spp. Peptostreptococcus micros Peptostreptococcus spp. 3 3 Gram-negative cocci Veillonella parvula 2 3 Veillonella spp. Other Gram-positive sporeforming rods 0 1 Gram-positive non-sporeforming rods Eubacterium 12 7 Lactobacillus fermentum 1 1 LactobaciUus ptantarum 2 2 Actinomyces odontolyticus 0 3 Other 0 1 Gram-negative rods Bacteroides asaccharolyticus 2 2 Bacteroides corrodens 0 4 Bacteroides ruminicola 8 8 Bacteroides ureolyticus 1 4 Bacteroides spp Eikenella corrodens 3 0 Fusobacterium nucleatum 10 8 Fusobacterium spp Total number of anaerobic isolates 107 t13 the patients showed abnormal levels of haemoglobin, SGOT, SGPT or alkaline phosphatases at any time during the study. Serum concentrations of penicillin and clindamycin indicated good patient compliance. Microbiological Findings. Twenty-three specimens contained exclusively anaerobic bacteria, while 34 yielded anaerobic and aerobic bacteria. In two specimens only aerobic bacteria were found and no microorganisms could be detected

4 1132 Eur. J. Clin. Microbiol. Infect. Dis a~ 80'._= 60' "6 C7 n rl A i i i "" i ' i i 1 i " I <0,0080, '5 1, Phenoxymethylpenieillin (mg/i) ' t 8O 60 '~ "6 g 4o 2o < , ,0 8.0 '16.0 Clindamycfn (mg/t) Figure 1: Susceptibility of the isolated anaerobic (~-) and aerobic (-*-) bacterial strains to phenoxymethylpenicillin (above) and clindamycin (below). in one specimen. A mean of 4.2 anaerobic strains were isolated from each anaerobic specimen, gram-negative rods being most common. A mean of 4.6 anaerobic strains and 2.2 aerobic strains were isolated from each specimen containing both anaerobes and aerobes. Gram-negative rods were the most common anaerobes while viridans streptococci were the most common aerobes (65 % of all aerobes detected). The two aerobic specimens yielded one aerobic strain each. The microbiological findings are presented in Table 2. Antibiotic Susceptibility. Data on susceptibility of the isolates to penicillin and clindamycin are given in Figure 1. No penicillin- or clindamycin- resistant strains could be isolated from the two patients who did not respond satisfactorily to treatment. A total of 38 (16.6 %) penicillin-resistant (MIC _> 1 mg/1) anaerobic strains were isolated from 23 (38 %) specimens, which were evenly distributed between the two patient groups (Table 3). Among these were 22 anaerobic gram-negative rods, mostly Bacteroides strains. Only five (2%) clindamycin-resistant (MIC > 4 mg/l) anaerobic strains were isolated from four specimens, all from patients in the penicillin group (Table 3). Adverse Effects. Adverse effects were observed in one patient in the penicillin group and in six

5 Vo1.11, Table 3." Anaerobic organisms resistant to penicillin (MIC ~ 1 mg/1) and/or clindamycin (MIC > 4 mg/l) isolated in the two treatment groups, MIC (rag/l) Patient Organism Antibiotic Penicillin Ciindamyein no. treatment 4 Bacteroides ureolyticus clindamycin > Eikenella corrodens penicillin Veillonella parvula Bacteroides ureolyticus clindamycin Fusobacterium nucleatum clindamycin 1 0,064 Bacteroides corrodens 2 0,125 9 Bacteroides rumin&ola penicillin 16 < Veillonella parvula I2 Fusobacterium nucleatum penicillin Bacteroides ureolyticus clindamycin Bacteroides sp. clindamycin Peptostreptococcusmicros penicillin Veillondla parvula penicillin Bacteroides sp. clindamycin Eubacterium sp. clindamycin i Bacteroides sp Bacteroides sp Acidaminococcusfermentans Bacteroides ruminicola clindamycin Veillonella parvula 4 0, Veillonellaparvula penicillin I,,actobacillus plantarum Peptostreptococcus micros penicillin 2 8 Bacteroides sp. 4 > Bacteroides corrodens clindamycin Eikenella corrodens penicillin Streptococcus intermedius penicillin Lactobacillus plantarum Eikenella corrodens penicillin Veillonellaparvula clindamycin > Bacteroides sp. penicillin 1 < Bacteroides sp. clindamycin VeiIlonella parvula clindamycin 2 0,25 55 Bacteroides ruminicola clindamycin 1 ~ Bacteroides sp. 1 0, Bacteroides ureolyticus penicillin _> Bacteroides sp Bacteroides sp. penicillin 1 0,125 Fusobacterium nucleatum 1 0,064 patients in the clindamycin group. The patient in the penicillin group had severe diarrhoea and withdrew from the study on day 2. One patient in the clindamycin group had mild gastrointestinal complaints combined with dizziness, two had mild to moderate diarrhoea and three experienced severe diarrhoea. Clostridium difficile and its toxins were detected on day 7 in faeces from one of the patients with severe diarrhoea. However, all patients recovered spontaneously within 12

6 1134 Eur. J. Clin. Microbiol. Infect. Dis. days from the start of treatment. No other adverse effects were observed. The difference in occurrence of adverse effects between the two treatment regimens was not statistically significant (Fisher's two-tailed exact test). Discussion Anaerobic bacteria are by far the most important pathogens in orofacial infections (3). Reports on increasing penicillin resistance among anaerobic bacteria (6, 7, 19, 20) confirm the need for an effective alternative agent to penicillin. The pus samples in the present study yielded 13.6 % penicillin-resistant anaerobic strains, mostly gram-negative rods, only slightly more than the 9.8 % reported by Gilmore et ai. (21). The resistant strains were however recovered from 38 % of the patients in the present study. Thus, the potential risk of orofacial infections with penicillin-resistant Bacteroides strains should not be discounted. It has also been demonstrated that a large number of Bacteroides strains isolated from the oral microflora in healthy volunteers are penicillin-resistant (10). As the penicillin-resistant strains were found as frequently in the penicillin as in the clindamycin group, the presence of penicillin-resistant pathogenic microorganisms does not necessarily result in clinical failure of penicillin therapy. Drainage is as important as antimicrobial treatment, and in these instances the favourable clinical response was probably due to the surgical intervention. However, when immediate drainage is not possible, such as in phlegmonous spread or in patients with dentistophobia, bacterial resistance may influence the clinical response to antimicrobial therapy. Several authors have reported cases of clinical failure of penicillin therapy of orofacial infections due to penicillin-resistant anaerobes (6-8, 22). Most of these patients subsequently responded to treatment with clindamycin or metronidazole. von Konow and Nord (15) conducted a study comparing a nitroimidazole, ornidazole, with penicillin and found ornidazole to be at least as effective as penicillin. Since virtually all anaerobic strains isolated from orofacial infections are highly sensitive to clindamycin in vitro (3), clindamycin was proposed as a potential alternative to penicillin. Gilmore et al. (21) recently undertook a study comparing penicillin to clindamycin in the treatment of odontogenic infec- tions and the results revealed a good clinical effect of both penicillin and clindamycin. In the present study the efficacy of treatment was evaluated by documenting the presence of fever, swelling, pain and sleep disturbance, reduction in the erythrocyte sedimentation rate and peripheral white blood cell count, and recurrence of infection or absence of a response to treatment. There tended to be a shorter duration of pain, fever and swelling in the clindamycin group. Thus there was a tendency for clindamycin to be slightly more efficacious than penicillin, with an earlier clinical response. Clindamycin has a significant impact on the indigenous gastrointestinal microflora (12) and occasionally gives rise to severe diarrhoea and even pseudomembranous colitis (11). In the present study a higher rate of adverse gastrointestinal effects was observed in the clindamycin group, and also severe diarrhoea due to Clostridium difficile. The data from the present study support the continued use of penicillin for the treatment of orofacial infections. When penicillin treatment fails due to infection with penicillin-resistant microorganisms or when patients are allergic to penicillin an alternative drug should be used. The findings of the present study are in accordance with earlier results (21), indicating that clindamycin is an effective alternative. However, associated adverse gastrointestinal effects limit the use of antimicrobial agents with a significant impact on the micro flora. References 1. Finegold SM, Baron E J, Wexler HM: A clinical guide to anaerobic infections. Star Publishing, Belmont, CA, Bartlett JG, O'Keefe P: The bacteriology of perimandibular space infections. Journal of Oral Surgery 1979, 37: yon Konow L, Nord CE, Nordenram ~: Anaerobic bacteria in dcntoalveolar infections. International Journal of Oral Surgery 1982, 10: Tabaqchali S: Anaerobic infections in the head and neck region. Scandinavian Journal of Infectious Diseases 1988, Supplement 57: Lewis MAO, MacFarlane TW, McGowan DA: A microbiological and clinical review of the acute dentoalveolar abscess. British Journal of Oral and Maxillofacial Surgery 1990, 28: Heimdahl A, yon Konow L, Nord CE: Isolation of ~-lactamase-producing Bacteroides strains associated with clinical failures with penicillin treatment of orofacial infections. Archives of Oral Biology 1980, 25:

7 Vo1.11, Heimdahl A, yon Konow L, Nord CE: Clinical significance of penicillin-resistant [3-1actamase-producing Bacteroides species in human orofacial infections. In: Ullman U (ed): Proceedings of the l~-lactam symposium. Springer, Kiel, 1983, p Bahn SL, Ciola B, Segal AG: Penicillin-resistant Bacteroides melaninogenicus infection in the mandible. Journal of Oral Surgery 1981, 39: Lewis MAO, MacFadane TW, McGowan DA: Antibiotic susceptibilities of bacteria isolated from acute dentoalveolar abscesses. Journal of AntimicrobiaI Chemotherapy 1989, 23: Heimdahi A, yon Konow L, Nord CE: 15-1actamaseproducing Bacteroides species in the oral cavity in the relation to penicillin therapy. Journal of Antimicrobial Chemotherapy 1981, 8: Aronsson B, Miillby R, Nord CE: Clostridium difficile and antibiotic associated diarrhoea in Sweden. Scandinavian Journal of Infectious Diseases 1982, Supplement 35: Nord CE, Kager L, Heimdahi A: Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. American Journal of Medicine 1984, 76: Bayliss R, Clarke C, Oakley CM, Sommerviile W, Whiffield AGW, Young SEJ: The microbiology and pathogenesis of infective endocarditis. British Heart Journal 1983, 50: Heimdahl A, Mattson T, Dahlliif G, L6nnqvist B, Ringd~n O: The oral cavity as a port of entry for early infections in patients treated with bone marrow transplantation. Oral Surgery, Oral Medicine, Oral Pathology 1989, 68: v0n Konow L, Nord CE: Ornidazale compared to phenoxymethylpeniciuin in the treatment of orofacial infections. Journal of Antimicrobial Chemotherapy 1983, 11: Lennette EH, Balows A, Hausler WJ, Shadomy ILl (ed): Manual of clinical microbiology. American Society for Microbiology, Washington, DC, Ericsson HM, Sherris JC: Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathologica et Microbiologica Scandinavica 1971, Supplement 217: Dornbusch K, Nord CE, Wadstriim 1":. Biochemical characterization and in vitro determination of antibiotic susceptibility of clinical isolates of Bacteroides fragilis. Scandinavian Journal of Infectious Diseases 1974, 6: Baker P J, Evans RT, Slots J, Genco R J: Antibiotic susceptibility of anaerobic bacteria from the human oral cavity. Journal of Dental Research 1985, 64: Edson RS, Rosenblatt JE, Lee DT, MeVey EA: Recent experience with antimicrobial susceptibility of anaerobic bacteria. Mayo Clinic Proceedings 1982, 57: Gilmore WC, Jacobus NV, Gorbaeh SL, Doku He, Tally FP: A prospective double-blind evaluation of penicillin versus clindamycin in the treatment of odontogenic infections. Journal of Oral and Maxillofacial Surgery 1988, 4: Whitcher BL, Belrne OR, Smith RA: Beta-lactamaseproducing Bacteroides melaninogenicus and osteomyelitis of the mandible. Journal of Oral Medicine 1983, 38:

ECOLOGICAL IMPACT OF NARROW SPECTRUM ANTIMICROBIAL AGENTS COMPARED TO BROAD SPECTRUM AGENTS ON THE HUMAN INTESTINAL MICROFLORA CARL ERIK NORD

ECOLOGICAL IMPACT OF NARROW SPECTRUM ANTIMICROBIAL AGENTS COMPARED TO BROAD SPECTRUM AGENTS ON THE HUMAN INTESTINAL MICROFLORA CARL ERIK NORD Old Herborn University Seminar Monograph 3: Consequences of antimicrobial therapy for the composition of the microflora of the digestive tract. Editors: Carl Erik Nord, Peter J. Heidt, Volker Rusch, and

More information

Antimicrobial Resistance in Human Oral and Intestinal Anaerobic Microfloras

Antimicrobial Resistance in Human Oral and Intestinal Anaerobic Microfloras ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1993, p. 1665-1669 Vol. 37, No. 8 0066-4804/93/081665-05$02.00/0 Copyright X 1993, American Society for Microbiology Antimicrobial Resistance in Human Oral and

More information

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION VIRBAC CORPORATION USA Product Label http://www.vetdepot.com P.O. BOX 162059, FORT WORTH, TX, 76161 Telephone: 817-831-5030 Order Desk: 800-338-3659 Fax: 817-831-8327 Website: www.virbacvet.com CLINTABS

More information

Reduce the risk of recurrence Clear bacterial infections fast and thoroughly

Reduce the risk of recurrence Clear bacterial infections fast and thoroughly Reduce the risk of recurrence Clear bacterial infections fast and thoroughly Clearly advanced 140916_Print-Detailer_Englisch_V2_BAH-05-01-14-003_RZ.indd 1 23.09.14 16:59 In bacterial infections, bacteriological

More information

Ciprofloxacin, Enoxacin, and Ofloxacin against Aerobic and

Ciprofloxacin, Enoxacin, and Ofloxacin against Aerobic and ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1988, p. 1143-1148 Vol., No. 8 0066-4804/88/081143-06$00/0 Copyright 1988, American Society for Microbiology Comparative Activities of, Amoxicillin-Clavulanic

More information

Elimination of bacteraemia after dental extraction: comparison of erythromycin and clindamycin for prophylaxis of infective endocarditis

Elimination of bacteraemia after dental extraction: comparison of erythromycin and clindamycin for prophylaxis of infective endocarditis Journal of Antimicrobial Chemotherapy (99) 7, 78-795 Elimination of bacteraemia after dental extraction: comparison of erythromycin and clindamycin for prophylaxis of infective endocarditis G. Hall', C.

More information

Basic principles of antibiotic use

Basic principles of antibiotic use Basic principles of antibiotic use Michal Holub Department of Infectious Diseases First Faculty of Medicine Charles University and Military University Hospital, Prague 1. Is antibiotical treatment indicated

More information

Secondary bacterial infections complicating skin lesions

Secondary bacterial infections complicating skin lesions J. Med. Microbiol. Vol. 51 (2002), 808 812 # 2002 Society for General Microbiology ISSN 0022-2615 REVIEW ARTICLE Secondary bacterial infections complicating skin lesions ITZHAK BROOK Department of Pediatrics,

More information

Anaerobic and microaerophilic gram-positive cocci Peptococcus species, Peptostreptococcus species, Microaerophilic streptococci

Anaerobic and microaerophilic gram-positive cocci Peptococcus species, Peptostreptococcus species, Microaerophilic streptococci CLINDACIN Composition Each capsule contains Clindamycin (as hydrochloride) 150 mg Capsule Action Clindamycin bind exclusively to the 50S subunit of bacterial ribosomes and suppress protein synthesis. Clindamycin

More information

Susceptibility of Respiratory Tract Anaerobes to Orally Administered Penicillins and Cephalosporins

Susceptibility of Respiratory Tract Anaerobes to Orally Administered Penicillins and Cephalosporins ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 1976, p. 713-720 Copyright 0 1976 American Society for Microbiology Vol. 10, No. 4 Printed in U.S.A. Susceptibility of Respiratory Tract Anaerobes to Orally

More information

amoxycillin/clavulanate vs placebo in the prevention of infection after animal

amoxycillin/clavulanate vs placebo in the prevention of infection after animal Archives of Emergency Medicine, 1989, 6, 251-256 A comparative double blind study of amoxycillin/clavulanate vs placebo in the prevention of infection after animal bites P. H. BRAKENBURY & C. MUWANGA Accident

More information

Effect of Lactobacillus F19 on the emergence of antibioticresistant microorganisms in the intestinal microflora

Effect of Lactobacillus F19 on the emergence of antibioticresistant microorganisms in the intestinal microflora Journal of Antimicrobial Chemotherapy (2004) 54, 791 797 DOI: 10.1093/jac/dkh406 Advance Access publication 25 August 2004 Effect of Lactobacillus F19 on the emergence of antibioticresistant microorganisms

More information

APPROVED PACKAGE INSERT. Each capsule contains clindamycin hydrochloride equivalent to 150 mg clindamycin base.

APPROVED PACKAGE INSERT. Each capsule contains clindamycin hydrochloride equivalent to 150 mg clindamycin base. APPROVED PACKAGE INSERT SCHEDULING STATUS: S4 PROPRIETARY NAMEAND DOSAGE FORM: DALACIN C TM 150 mg (Capsules) COMPOSITION: Each capsule contains clindamycin hydrochloride equivalent to 150 mg clindamycin

More information

Intra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018

Intra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018 Intra-Abdominal Infections Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018 Select guidelines Mazuski JE, et al. The Surgical Infection

More information

Community-Associated C. difficile Infection: Think Outside the Hospital. Maria Bye, MPH Epidemiologist May 1, 2018

Community-Associated C. difficile Infection: Think Outside the Hospital. Maria Bye, MPH Epidemiologist May 1, 2018 Community-Associated C. difficile Infection: Think Outside the Hospital Maria Bye, MPH Epidemiologist Maria.Bye@state.mn.us 651-201-4085 May 1, 2018 Clostridium difficile Clostridium difficile Clostridium

More information

Present Status of Therapy for Anaerobic Infections

Present Status of Therapy for Anaerobic Infections 89 Present Status of Therapy for Anaerobic Infections Sydney M. Finegold and Hannah M. Wexler From the Medical and Research Services, Veterans Affairs Medical Center West Los Angeles, and the Department

More information

THERAPY OF ANAEROBIC INFECTIONS LUNG ABSCESS BRAIN ABSCESS

THERAPY OF ANAEROBIC INFECTIONS LUNG ABSCESS BRAIN ABSCESS THERAPY OF ANAEROBIC INFECTIONS Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu LUNG ABSCESS A lung abscess is a localized pus cavity in

More information

Who should read this document? 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version? 3

Who should read this document? 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version? 3 Neurosurgical infections (adult only) Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): as above Authors Division: DCSS & Tertiary

More information

An Evidence Based Approach to Antibiotic Prophylaxis in Oral Surgery

An Evidence Based Approach to Antibiotic Prophylaxis in Oral Surgery An Evidence Based Approach to Antibiotic Prophylaxis in Oral Surgery Nicholas Makhoul DMD. MD. FRCD(C). Dip ABOMS. FACS. Director, Division of Oral and Maxillofacial Surgery Assistant Professor McGill

More information

Amoxicillin dose for gum infection

Amoxicillin dose for gum infection Amoxicillin dose for gum infection Learn about Prilosec (Omeprazole) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications. 30-9-1990 Amoxicillin

More information

Antibiotic Prophylaxis Update

Antibiotic Prophylaxis Update Antibiotic Prophylaxis Update Choosing Surgical Antimicrobial Prophylaxis Peri-Procedural Administration Surgical Prophylaxis and AMS at Epworth HealthCare Mr Glenn Valoppi Dr Trisha Peel Dr Joseph Doyle

More information

Bacterial skin and soft tissues infections (SSTI) are one of the most common 1. infections among different age groups

Bacterial skin and soft tissues infections (SSTI) are one of the most common 1. infections among different age groups Bacterial skin and soft tissues infections (SSTI) are one of the most common 1 infections among different age groups Gram-positive bacteria are the most frequently isolated pathogens from SSTI, with a

More information

General Approach to Infectious Diseases

General Approach to Infectious Diseases General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor

More information

on February 12, 2018 by guest

on February 12, 2018 by guest AAC Accepted Manuscript Posted Online 12 February 2018 Antimicrob. Agents Chemother. doi:10.1128/aac.00047-18 Copyright 2018 Stapert et al. This is an open-access article distributed under the terms of

More information

Clinical Policy: Clindamycin (Cleocin) Reference Number: CP.HNMC.08 Effective Date: Last Review Date: Line of Business: Medicaid - HNMC

Clinical Policy: Clindamycin (Cleocin) Reference Number: CP.HNMC.08 Effective Date: Last Review Date: Line of Business: Medicaid - HNMC Clinical Policy: (Cleocin) Reference Number: CP.HNMC.08 Effective Date: 07.01.17 Last Review Date: 02.18 Line of Business: Medicaid - HNMC Revision Log See Important Reminder at the end of this policy

More information

AMOCLAN HIKMA PHARMACEUTICALS

AMOCLAN HIKMA PHARMACEUTICALS 09-15 AMOCLAN HIKMA PHARMACEUTICALS (Amoxycillin and Clavulanic acid) ACTION Amoxicillin is a semisynthetic antibiotic with a broad spectrum of bactericidal activity against many gram-positive and gram-negative

More information

.'URRENT THERAPEUTIC RESEA. VOLUME 66, NUMBER 3, MAY/JuNE 2005

.'URRENT THERAPEUTIC RESEA. VOLUME 66, NUMBER 3, MAY/JuNE 2005 .'URRENT THERAPEUTIC RESEA VOLUME 66, NUMBER 3, MAY/JuNE 2005 Efficacy of Moxifloxacin Monotherapy Versus Gatifloxacin Monotherapy, Piperacillin- Tazobactam Combination Therapy, and Clindamycin Plus Gentamicin

More information

Secondary peritonitis

Secondary peritonitis Secondary peritonitis Caused by spillage of gastrointestinal microorganisms into the peritoneal cavity secondary to loss of the integrity of the mucosal barriers Etiology: perforation of peptic ulcer traumatic

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Reference Number: CP.HNMC.24 Effective Date: 07.01.17 Last Review Date: 02.18 Line of Business: Medicaid - HNMC Revision Log See Important Reminder at the end of this policy for important

More information

NON-SPORING ANAEROBES

NON-SPORING ANAEROBES 36 NON-SPORING ANAEROBES 36.1 INTRODUCTION Anaerobic bacteria are widespread and very important. They do not require oxygen for growth, which is often toxic for them. They lack the enzymes superoxide dismutase,

More information

Effect of dalbavancin on the normal intestinal microflora

Effect of dalbavancin on the normal intestinal microflora Journal of Antimicrobial Chemotherapy (00), 1 doi:10.109/jac/dkl1 Advance Access publication 1 July 00 Effect of dalbavancin on the normal intestinal microflora Carl Erik Nord*, Gundars Rasmanis and Elisabeth

More information

Tel: Fax:

Tel: Fax: CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.

More information

Role of the nurse in diagnosing infection: The right sample, every time

Role of the nurse in diagnosing infection: The right sample, every time BROUGHT TO YOU BY Role of the nurse in diagnosing infection: The right sample, every time The module has been written by Shanika Anne-Marie Crusz and Amelia Joseph Authors affiliation: Department of Clinical

More information

Effects of Minocycline and Other Antibiotics on Fusobacterium necrophorum Infections in Mice

Effects of Minocycline and Other Antibiotics on Fusobacterium necrophorum Infections in Mice ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1975, p. 421-425 Copyright 0 1975 American Society for Microbiology Vol. 7, No. 4 Printed in U.S.A. Effects of Minocycline and Other s on Fusobacterium necrophorum

More information

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015 Aberdeen Hospital Antibiotic Susceptibility Patterns For Commonly Isolated s For 2015 Services Laboratory Microbiology Department Aberdeen Hospital Nova Scotia Health Authority 835 East River Road New

More information

Mrsa abscess and cellulitis

Mrsa abscess and cellulitis Search Mrsa abscess and cellulitis An abscess is a collection of pus that has built up within the tissue of the body. Signs and symptoms of abscesses include redness, pain, warmth, and swelling. The. Staph

More information

Antibiotics & treatment of Acute Bcterial Sinusitis. Walid Reda Product Manager. Do your antimicrobial options meet your needs?

Antibiotics & treatment of Acute Bcterial Sinusitis. Walid Reda Product Manager. Do your antimicrobial options meet your needs? Antibiotics & treatment of Acute Bcterial Sinusitis Walid Reda Product Manager Do your antimicrobial options meet your needs? Antimicrobial Effects: What s involved? Effect in Humans: Serum concentration

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur... SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT WONDERCEF powder and solvent for solution for injection for horses not intended for the production of foods for human consumption.

More information

B. PACKAGE LEAFLET 1

B. PACKAGE LEAFLET 1 B. PACKAGE LEAFLET 1 PACKAGE LEAFLET NICILAN 400 mg/100 mg tablets for dogs 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH

More information

Classification of Bacteria

Classification of Bacteria Classification of Bacteria MICROBIOLOGY -TAXONOMY Taxonomy is the system to classify living organisms Seven groups kingdom, phylum or div, class, order, family, genus, species Binomial system of nomenclature

More information

Critical Appraisal Topic. Antibiotic Duration in Acute Otitis Media in Children. Carissa Schatz, BSN, RN, FNP-s. University of Mary

Critical Appraisal Topic. Antibiotic Duration in Acute Otitis Media in Children. Carissa Schatz, BSN, RN, FNP-s. University of Mary Running head: ANTIBIOTIC DURATION IN AOM 1 Critical Appraisal Topic Antibiotic Duration in Acute Otitis Media in Children Carissa Schatz, BSN, RN, FNP-s University of Mary 2 Evidence-Based Practice: Critical

More information

Scottish Medicines Consortium

Scottish Medicines Consortium Scottish Medicines Consortium daptomycin 350mg powder for concentrate for solution for infusion (Cubicin ) Chiron Corporation Limited No. (248/06) 10 March 2006 The Scottish Medicines Consortium (SMC)

More information

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria

More information

Felipe N. Gutierrez MD, MPH Chief, Infectious Diseases Phoenix VA Healthcare

Felipe N. Gutierrez MD, MPH Chief, Infectious Diseases Phoenix VA Healthcare Felipe N. Gutierrez MD, MPH Chief, Infectious Diseases Phoenix VA Healthcare 100% of all wounds will yield growth If you get a negative culture you something is wrong! Pseudomonas while ubiquitous does

More information

Should we test Clostridium difficile for antimicrobial resistance? by author

Should we test Clostridium difficile for antimicrobial resistance? by author Should we test Clostridium difficile for antimicrobial resistance? Paola Mastrantonio Department of Infectious Diseases Istituto Superiore di Sanità, Rome,Italy Clostridium difficile infection (CDI) (first

More information

Burn Infection & Laboratory Diagnosis

Burn Infection & Laboratory Diagnosis Burn Infection & Laboratory Diagnosis Introduction Burns are one the most common forms of trauma. 2 million fires each years 1.2 million people with burn injuries 100000 hospitalization 5000 patients die

More information

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1 Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director

More information

against Clinical Isolates of Gram-Positive Bacteria

against Clinical Isolates of Gram-Positive Bacteria ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,

More information

Diabetic Foot Infection. Dr David Orr Consultant Microbiologist Lancashire Teaching Hospitals

Diabetic Foot Infection. Dr David Orr Consultant Microbiologist Lancashire Teaching Hospitals Diabetic Foot Infection Dr David Orr Consultant Microbiologist Lancashire Teaching Hospitals History of previous amputation [odds ratio (OR)=19.9, P=.01], Peripheral vascular disease (OR=5.5, P=.007)

More information

Resistance pattern of anaerobic bacteria isolated in a general hospital during a two-year period

Resistance pattern of anaerobic bacteria isolated in a general hospital during a two-year period Journal of Antimicrobial Chemotherapy (9), Supp. D, 9 6 Resistance pattern of anaerobic bacteria isolated in a general hospital during a two-year period J. F. Acar, F. W. Goldstein, M. D. Kitzis and M.

More information

Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu

Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu Search for: Search Search Does levaquin cover anaerobes Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu Levofloxacin, sold under the trade names Levaquin among others, is an antibiotic.

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Amfipen LA 100 mg/ml suspension for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance: Each ml contains:

More information

SESSION XVI NEW ANTIBIOTICS

SESSION XVI NEW ANTIBIOTICS SESSION XVI NEW ANTIBIOTICS New Antibiotics to Treat Anaerobic Infections 2 Goldstein, E.J.C.;* Citron, D.M. Antibiotic Pharmacodynamics 3 Stein, G.E.* Targeting Selenium Metabolism in Stickland Fermentors:

More information

Healthcare-associated Infections Annual Report December 2018

Healthcare-associated Infections Annual Report December 2018 December 2018 Healthcare-associated Infections Annual Report 2011-2017 TABLE OF CONTENTS INTRODUCTION... 1 METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS... 2 MRSA SURVEILLANCE... 3 CLOSTRIDIUM

More information

Susceptibility Testing of Anaerobic Bacteria: Evaluation of the Redesigned (Version 96) biomérieux ATB ANA Device

Susceptibility Testing of Anaerobic Bacteria: Evaluation of the Redesigned (Version 96) biomérieux ATB ANA Device JOURNAL OF CLINICAL MICROBIOLOGY, June 1999, p. 1824 1828 Vol. 37, No. 6 0095-1137/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Susceptibility Testing of Anaerobic

More information

Principles of Antimicrobial Therapy

Principles of Antimicrobial Therapy Principles of Antimicrobial Therapy Doo Ryeon Chung, MD, PhD Professor of Medicine, Division of Infectious Diseases Director, Infection Control Office SUNGKYUNKWAN UNIVERSITY SCHOOL OF MEDICINE CASE 1

More information

gingivitis: periodontitis: dental caries: palatinitis: oral pharyngitis and tonsillitis: mouth abscess: glossitis: oro-sinus fistula: gingivitis:

gingivitis: periodontitis: dental caries: palatinitis: oral pharyngitis and tonsillitis: mouth abscess: glossitis: oro-sinus fistula:  gingivitis: ABSTRACT Mouth is one of the anatomical segments of the digestive microbiota which is characterized by a marked diversity. Among the multitude of microorganisms that inhabit the oral mucosa at a time,

More information

Ecological impact of the des-f(6)-quinolone, BMS , on the normal intestinal microflora C. E. Nord 1, D. A. Gajjar 2 and D. M.

Ecological impact of the des-f(6)-quinolone, BMS , on the normal intestinal microflora C. E. Nord 1, D. A. Gajjar 2 and D. M. ORIGINAL ARTICLE Ecological impact of the des-f(6)-quinolone, BMS-284756, on the normal intestinal microflora C. E. Nord 1, D. A. Gajjar 2 and D. M. Grasela 2 1 Department of Microbiology, Pathology and

More information

number Done by Corrected by Doctor Dr.Malik

number Done by Corrected by Doctor Dr.Malik number 27 Done by Fatimah Farhan Corrected by Basil Al-Bakri Doctor Dr.Malik Note: anything in red is just extra info and you will not be asked about it in the exam. In this sheet we will continue talking

More information

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER University of Minnesota Health University of Minnesota Medical Center University of Minnesota Masonic Children s Hospital May 2017 Printed herein are

More information

Chapter Anaerobic infections (individual fields): prevention and treatment of postoperative infections

Chapter Anaerobic infections (individual fields): prevention and treatment of postoperative infections J Infect Chemother (2011) 17 (Suppl 1):62 66 DOI 10.1007/s10156-010-0141-x GUIDELINES Chapter 2-5-1. Anaerobic infections (individual fields): prevention and treatment of postoperative infections Ó Japanese

More information

Source: Portland State University Population Research Center (

Source: Portland State University Population Research Center ( Methicillin Resistant Staphylococcus aureus (MRSA) Surveillance Report 2010 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Health Authority Updated:

More information

CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Antibiotics One of the most commonly used group of drugs In USA 23

More information

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants Study Title Antibacterial Activity and Efficacy of E-Mist Innovations' Electrostatic Sprayer Product with Multiple Disinfectants Method Modified Association of Analytical Communities Method 961.02 Modified

More information

Anaerobic bacteria in 118 patients with deepspace head and neck infections from the University Hospital of Maxillofacial Surgery, Sofia, Bulgaria

Anaerobic bacteria in 118 patients with deepspace head and neck infections from the University Hospital of Maxillofacial Surgery, Sofia, Bulgaria Journal of Medical Microbiology (2006), 55, 1285 1289 DOI 10.1099/jmm.0.46512-0 Anaerobic bacteria in 118 patients with deepspace head and neck infections from the University Hospital of Maxillofacial

More information

Jan A. Jacobs* and Ellen E. Stobberingh

Jan A. Jacobs* and Ellen E. Stobberingh Journal of Antimicrobial Chemotherapy (996) 37, 37-375 In-vitro antimicrobial susceptibility of the 'Streptococcus millerv group {Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius)

More information

Summary of Product Characteristics

Summary of Product Characteristics Summary of Product Characteristics 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Cefenil 50 mg/ml Powder and Solvent for Solution for Injection for and. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Powder vial

More information

Epidemiology and Antimicrobial Susceptibility of Anaerobic Bloodstream Infections: A 10 Years Study

Epidemiology and Antimicrobial Susceptibility of Anaerobic Bloodstream Infections: A 10 Years Study JMID/ 2018; 8 (4):135-139 Journal of Microbiology and Infectious Diseases doi: 10.5799/xxxxx RESEARCH ARTICLE Epidemiology and Antimicrobial Susceptibility of Anaerobic Bloodstream Infections: A 10 Years

More information

11/2/2015. Update on the Treatment of Clostridium difficile Infections. Disclosure. Objectives

11/2/2015. Update on the Treatment of Clostridium difficile Infections. Disclosure. Objectives Update on the Treatment of Clostridium difficile Infections Spencer H. Durham, Pharm.D.,BCPS (AQ-ID) Assistant Clinical Professor of Pharmacy Practice Auburn University Harrison School of Pharmacy Kurt

More information

Part II SUMMARY OF PRODUCT CHARACTERISTICS. Each tablet contains 25 mg Clindamycin (as Clindamycin Hydrochloride)

Part II SUMMARY OF PRODUCT CHARACTERISTICS. Each tablet contains 25 mg Clindamycin (as Clindamycin Hydrochloride) Clindacyl 25mg Tablets Vm 08007/4104 Part II SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT CLINDACYL 25 MG TABLETS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Anaerobic Bacteria in Intra-Abdominal Infections and Bacteremia Maria Hedberg, Umeå University, Umeå, Sweden Anaerobic Bacteria: Next Generation Technology Meets Anaerobic Diagnostics ESCMID Postgraduate

More information

Micrococcus. May be normal present in upper respiratory tract. - Grow on ordinary media Nutrient agar - Blood agar and. M. luteus.

Micrococcus. May be normal present in upper respiratory tract. - Grow on ordinary media Nutrient agar - Blood agar and. M. luteus. Micrococcus Morphology: - Gram +ve cocci - Arrangement : Tetrades - Non motile, non capsulated, non sporulated Habitat: May be normal present in upper respiratory tract Species : 1- M.varians 2- M. luteus

More information

Labquality External Quality Assesment Programmes General Bacteriology 1 3/2010

Labquality External Quality Assesment Programmes General Bacteriology 1 3/2010 Labquality External Quality Assesment Programmes General Bacteriology 1 3/2010 Photos and text: Markku Koskela, M.D., Ph.D. Clinical microbiology specialist Oulu, Finland Patient and sample 9/2010 Pus

More information

Responsible use of antibiotics

Responsible use of antibiotics Responsible use of antibiotics Uga Dumpis MD, PhD Department of Infectious Diseases and Infection Control Pauls Stradiņs Clinical University Hospital Challenges in the hospitals Antibiotics are still effective

More information

Scottish Medicines Consortium

Scottish Medicines Consortium Scottish Medicines Consortium tigecycline 50mg vial of powder for intravenous infusion (Tygacil ) (277/06) Wyeth 9 June 2006 The Scottish Medicines Consortium (SMC) has completed its assessment of the

More information

Antibacterials. Recent data on linezolid and daptomycin

Antibacterials. Recent data on linezolid and daptomycin Antibacterials Recent data on linezolid and daptomycin Patricia Muñoz, MD. Ph.D. (pmunoz@micro.hggm.es) Hospital General Universitario Gregorio Marañón Universidad Complutense de Madrid. 1 GESITRA Reasons

More information

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production

More information

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases Appropriate Management of Common Pediatric Infections Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases It s all about the microorganism The common pathogens Viruses

More information

Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece

Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece Journal of Antimicrobial Chemotherapy (2008) 62, 137 141 doi:10.1093/jac/dkn134 Advance Access publication 1 April 2008 Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in

More information

The Current Concepts in the Use of Antibiotics in Dental Practice

The Current Concepts in the Use of Antibiotics in Dental Practice The Current Concepts in the Use of Antibiotics in Dental Practice 1 Dr. Shivanand S Associate Professor Department of oral and Maxillofacial Surgery 2 Dr. Vidya G Doddawad Associate Professor Department

More information

QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)

QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.) Pseudomonas aeruginosa (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.) Description: Greenish gray colonies with some beta-hemolysis around each colony on blood agar (BAP),

More information

moxifloxacin intravenous, 400mg/250mL, solution for infusion (Avelox ) SMC No. (650/10) Bayer Schering

moxifloxacin intravenous, 400mg/250mL, solution for infusion (Avelox ) SMC No. (650/10) Bayer Schering moxifloxacin intravenous, 400mg/250mL, solution for infusion (Avelox ) SMC No. (650/10) Bayer Schering 05 November 2010 The Scottish Medicines Consortium (SMC) has completed its assessment of the above

More information

Surgical prophylaxis for Gram +ve & Gram ve infection

Surgical prophylaxis for Gram +ve & Gram ve infection Surgical prophylaxis for Gram +ve & Gram ve infection Professor Mark Wilcox Clinical l Director of Microbiology & Pathology Leeds Teaching Hospitals & University of Leeds, UK Heath Protection Agency Surveillance

More information

Intra-abdominal anaerobic infections. Diagnostics and therapy

Intra-abdominal anaerobic infections. Diagnostics and therapy Intra-abdominal anaerobic infections. Diagnostics and therapy Elisabeth Nagy MD. PhD. DSc. Institute of Clinical Microbiology, Faculty of Medicine, University of Szeged 4th ESCMID School, Szeged, Hungary

More information

Clostridium difficile Colitis

Clostridium difficile Colitis Update on Clostridium difficile Colitis Fredrick M. Abrahamian, D.O., FACEP Associate Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA

More information

Infection Comments First Line Agents Penicillin Allergy History of multiresistant. line treatment: persist for >7 days they may be

Infection Comments First Line Agents Penicillin Allergy History of multiresistant. line treatment: persist for >7 days they may be Gastrointestinal Infections Infection Comments First Line Agents Penicillin Allergy History of multiresistant Campylobacter Antibiotics not recommended. Erythromycin 250mg PO 6 Alternative to first N/A

More information

Int.J.Curr.Microbiol.App.Sci (2017) 6(3):

Int.J.Curr.Microbiol.App.Sci (2017) 6(3): International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 3 (2017) pp. 891-895 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.603.104

More information

Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents

Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents Journal of Antimicrobial Chemotherapy (2004) 53, 1039 1044 DOI: 10.1093/jac/dkh248 Advance Access publication 5 May 2004 Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic

More information

Empiric Treatment of Sepsis. Professor of Clinical Microbiology Department of Microbiology Leicester University U. K.

Empiric Treatment of Sepsis. Professor of Clinical Microbiology Department of Microbiology Leicester University U. K. VOL. 38 NO. 8 CHEMO THERAPY Empiric Treatment of Sepsis Emmerson A M Professor of Clinical Microbiology Department of Microbiology Leicester University U. K. Empiric Treatment of Sepsis The treatment of

More information

Management of Native Valve

Management of Native Valve Management of Native Valve Infective Endocarditis 2005 AHA 2015 Baddour LM, et al. Circulation. 2015;132(15):1435-86 2009 ESC 2015 Habib G, et al. Eur Heart J. 2015;36(44):3075-128 ESC 2015: Endocarditis

More information

Epidemiology and Microbiology of Surgical Wound Infections

Epidemiology and Microbiology of Surgical Wound Infections JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2000, p. 918 922 Vol. 38, No. 2 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Epidemiology and Microbiology of Surgical

More information

Comparison of Clindamycin, Erythromycin, and Methicillin in Streptococcal Infections in Monkeys

Comparison of Clindamycin, Erythromycin, and Methicillin in Streptococcal Infections in Monkeys ANTIbMCROBIAL AGENTS AND CHEMOTHERAPY, June 197, p. 460-465 Copyright 197 American Society for Microbiology Vol. 1, No. 6 Printed in U.S.A. Comparison of Clindamycin, Erythromycin, and Methicillin in Streptococcal

More information

CLINICAL USE OF BETA-LACTAMS

CLINICAL USE OF BETA-LACTAMS CLINICAL USE OF BETA-LACTAMS Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu WHY IS INFECTIOUS DISEASE PHARMACOTHERAPY SO CONFUSING? Microbial

More information

BACTERIOLOGY OF THE HEALTHY CONJUNCTIVA*

BACTERIOLOGY OF THE HEALTHY CONJUNCTIVA* Brit. J. Ophthal. (1954), 38, 719. BACTERIOLOGY OF THE HEALTHY CONJUNCTIVA* BY C. H. SMITH Department of Pathology, Institute of Ophthalmology, University of London THE normal bacterial flora of the mucous

More information

Who should read this document 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version 3. Policy/Procedure/Guideline 3

Who should read this document 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version 3. Policy/Procedure/Guideline 3 Antibiotic Prophylaxis in Cranial Neurosurgery Antibiotic Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): as above Authors Division: DCSS & Tertiary

More information

Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.

Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity. Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity. Cephalosporins are divided into Generations: -First generation have better activity against gram positive organisms. -Later compounds

More information

Presented at Central Veterinary Conference, Kansas City, MO, August 2013; Copyright 2013, P.L Ruegg, all rights reserved

Presented at Central Veterinary Conference, Kansas City, MO, August 2013; Copyright 2013, P.L Ruegg, all rights reserved MILK MICROBIOLOGY: IMPROVING MICROBIOLOGICAL SERVICES FOR DAIRY FARMS Pamela L. Ruegg, DVM, MPVM, University of WI, Dept. of Dairy Science, Madison WI 53705 Introduction In spite of considerable progress

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Anaerobic infections: antibiotic therapy and development of resistance Inge C Gyssens 1 0ctober 2014 Objectives To review the clinical aspects of some anaerobic infections To understand the epidemiology

More information

THE VETERINARIAN'S CHOICE. Compendium clinical Trials. Introducing new MILPRO. from Virbac. Go pro. Go MILPRO..

THE VETERINARIAN'S CHOICE. Compendium clinical Trials. Introducing new MILPRO. from Virbac. Go pro. Go MILPRO.. THE VETERINARIAN'S CHOICE. Introducing new MILPRO from Virbac. Compendium clinical Trials Go pro. Go MILPRO.. milbemycin/praziquantel Content INTRODUCTION 05 I. EFFICACY STUDIES IN CATS 06 I.I. Efficacy

More information

Drug resistance in relation to use of silver sulphadiazine cream in a burns unit

Drug resistance in relation to use of silver sulphadiazine cream in a burns unit J. clin. Path., 1977, 30, 160-164 Drug resistance in relation to use of silver sulphadiazine cream in a burns unit KIM BRIDGES AND E. J. L. LOWBURY From the MRC Industrial Injuries and Burns Unit, Birmingham

More information